What Infliximab treats
Infliximab is a monoclonal antibody biologic medication used to treat several autoimmune and inflammatory conditions, including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It works by targeting and neutralizing tumor necrosis factor-alpha (TNF-alpha), a key protein involved in inflammation.
Benefits of Infliximab
Patients treated with infliximab may experience:
- Relief from joint swelling, pain, and stiffness
- Reduction in gastrointestinal symptoms and flare-ups
- Improved skin appearance in psoriasis
- Fewer disease flares and improved physical functioning
- Long-term control of inflammation and disease progression
Infliximab has been in use for over two decades and is a trusted option in managing complex inflammatory diseases.
Possible Side Effects of Infliximab
Common side effects may include:
- Headache
- Nausea
- Fatigue
- Upper respiratory infections
- Infusion-related reactions (e.g., fever, chills, rash)
Serious risks, though rare, include:
- Increased risk of infections like tuberculosis
- Liver enzyme abnormalities
- Blood disorders
- Rare neurologic or autoimmune complications
- Risk of certain malignancies in long-term use
Patients typically undergo screening for infections prior to starting infliximab, and regular monitoring is advised during treatment.
How infusion works at Prime
Infliximab is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Infliximab, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
How Does Infliximab Work?
Infliximab works by binding to TNF-alpha, a cytokine that drives inflammation in autoimmune diseases. By neutralizing TNF-alpha, infliximab helps to reduce immune system overactivity, easing symptoms like joint pain, bowel inflammation, and skin lesions. The medication is administered via intravenous infusion, typically in a healthcare setting, with dosing intervals that vary by condition.
Who is Infliximab For?
Infliximab is FDA-approved for adults and children (as young as 6 years old for some conditions) with:
- Moderate to severe rheumatoid arthritis (with methotrexate)
- Moderate to severe Crohn’s disease
- Moderate to severe ulcerative colitis
- Psoriatic arthritis
- Ankylosing spondylitis
- Chronic severe plaque psoriasis
It is usually prescribed for patients who have not responded well to conventional treatments.